Fresenius Medical Care Renal Therapies Group, LLC
Explore this company’s associated devices, FDA decisions and regulatory history.

Fresenius Medical Care Renal Therapies Group, LLC
- Regulatory records
- 5
- Linked recall entries
- 9
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 5 FDA records to the applicant name Fresenius Medical Care Renal Therapies Group, LLC. The collection includes 5 510(k) clearances. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jan 29, 2026 to Oct 19, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code KDI appears in 4 of the 5 linked filings. The collection spans 2 FDA product codes. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 920 Winter St., Waltham, MA, 02451, US. Recorded on K261203, decision dated Oct 19, 2026.
Device categories in this collection
Dialyzer, High Permeability With Or Without Sealed Dialysate System; Dialysate Concentrate For Hemodialysis (Liquid Or Powder).
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Recalls linked to this firm
MedtechLedger links 9 FDA enforcement entries through the recorded recalling firm or an exact submission number published in FDA’s recall data. 9 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.
| Recall / product | Company | Classification | Report date | Source |
|---|---|---|---|---|
| Fresenius Medical Care Renal Therapies Group, LLC | Class II | Sep 30, 2026 | FDA | |
| Fresenius Medical Care Renal Therapies Group, LLC | Class II | Sep 9, 2026 | FDA | |
| Fresenius Medical Care Renal Therapies Group, LLC | Class II | Sep 9, 2026 | FDA | |
| Fresenius Medical Care Renal Therapies Group, LLC | Class II | Sep 9, 2026 | FDA | |
| Fresenius Medical Care Renal Therapies Group, LLC | Class II | Sep 9, 2026 | FDA | |
| Fresenius Medical Care Renal Therapies Group, LLC | Class II | Sep 9, 2026 | FDA |
Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.
Search the firm’s recall recordsSource updated Nov 11, 2026. Retrieved Nov 21, 2026.
Regulatory record history
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
multiFiltratePRO SystemK261203 | Fresenius Medical Care Renal Therapies Group, LLC | 510(k) clearance | Oct 19, 2026 | FDA |
| Fresenius Medical Care Renal Therapies Group, LLC | 510(k) clearance | Jul 24, 2026 | FDA | |
| Fresenius Medical Care Renal Therapies Group, LLC | 510(k) clearance | May 15, 2026 | FDA | |
| Fresenius Medical Care Renal Therapies Group, LLC | 510(k) clearance | Feb 10, 2026 | FDA | |
| Fresenius Medical Care Renal Therapies Group, LLC | 510(k) clearance | Jan 29, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.





